She is Director of Stem Cell and Pathology Core at the same university and Director of Biomarker Core in the NIH CAESAR. In these capacities, she has been directing two vigorous research laboratories and investigating the mechanisms responsible for myocardial ischemia/reperfusion injury and developing the cardioprotective strategies in the fields of gene therapy and stem cell therapy for 18 years.